These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33094841)

  • 1. Investigating the missing heritability of fetal haemoglobin level in Africa.
    Wonkam A
    Br J Haematol; 2020 Dec; 191(5):668-670. PubMed ID: 33094841
    [No Abstract]   [Full Text] [Related]  

  • 2. Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies.
    Lettre G; Bauer DE
    Lancet; 2016 Jun; 387(10037):2554-64. PubMed ID: 27353686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cellular basis of haemoglobin switching: further studies of fetal-to-adult haemopoietic cell transplantation.
    Wood WG; Bunch C; Kelly S
    Prog Clin Biol Res; 1985; 191():369-82. PubMed ID: 2413476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Double-Hit and Double-Expressor Phenotypes in Relapsed Aggressive B-Cell Lymphomas Treated With Autologous Hematopoietic Stem Cell Transplantation.
    Smith SM
    J Clin Oncol; 2017 Jan; 35(1):1-3. PubMed ID: 28034063
    [No Abstract]   [Full Text] [Related]  

  • 5. Autologous stem cell transplant in first remission for transformed indolent non-Hodgkin lymphoma: additional data to guide practice.
    Reneau JC; William BM
    Br J Haematol; 2020 Dec; 191(5):663-665. PubMed ID: 33065776
    [No Abstract]   [Full Text] [Related]  

  • 6. Diffuse large B-cell lymphoma: the challenge of relapse after an autologous stem cell transplant.
    Robinson SP
    Bone Marrow Transplant; 2017 Feb; 52(2):199-200. PubMed ID: 27869811
    [No Abstract]   [Full Text] [Related]  

  • 7. Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma.
    Galli E; Sorà F; Hohaus S; Bellesi S; Autore F; Metafuni E; Innocenti I; Marra J; Fresa A; Limongiello MA; Giammarco S; Leccisotti L; Guarneri A; Chiusolo P; Laurenti L; Teofili L; Piccirillo N; Bacigalupo A; Sica S
    Bone Marrow Transplant; 2022 May; 57(5):837-839. PubMed ID: 35260803
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence of late onset neutropenia associated with rituximab use in B cell lymphoma patients undergoing autologous stem cell transplantation.
    Ha VH; Ghosh S; Leyshon C; Ryan N; Chambers CR; Stewart DA
    J Oncol Pharm Pract; 2018 Jul; 24(5):323-331. PubMed ID: 28358279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab and autologous stem-cell transplantation for high-risk diffuse large B-cell lymphoma.
    Tanimoto T; Oshima K; Tsuda K; Mori J; Shimmura H
    Lancet Oncol; 2017 Oct; 18(10):e557. PubMed ID: 28971816
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemoglobin synthesis by fetal erythroid cells in an adult environment.
    Bunch C; Wood WG; Weatherall DJ; Robinson JS; Corp MJ
    Br J Haematol; 1981 Nov; 49(3):325-36. PubMed ID: 6170306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should patient age be an obstacle for high-dose therapy and stem cell rescue?
    Dann EJ
    Leuk Res; 2019 Mar; 78():34-35. PubMed ID: 30711890
    [No Abstract]   [Full Text] [Related]  

  • 12. Fetal-to-adult hemopoietic cell transplantation: is hemoglobin synthesis gestational age-dependent?
    Wood WG; Bunch C
    Prog Clin Biol Res; 1983; 134():511-21. PubMed ID: 6198664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab and autologous stem-cell transplantation for high-risk diffuse large B-cell lymphoma - Authors' reply.
    Chiappella A; Martelli M; Evangelista A; Vitolo U
    Lancet Oncol; 2017 Oct; 18(10):e558. PubMed ID: 28971817
    [No Abstract]   [Full Text] [Related]  

  • 14. Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival.
    Dean R; Masci P; Pohlman B; Andresen S; Serafino S; Sobecks R; Kuczkowski E; Curtis J; Maciejewski J; Rybicki L; Kalaycio M; Hsi E; Theil K; Bolwell BJ
    Bone Marrow Transplant; 2005 Dec; 36(12):1049-52. PubMed ID: 16247431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome wide association study of fetal hemoglobin in sickle cell anemia in Tanzania.
    Mtatiro SN; Singh T; Rooks H; Mgaya J; Mariki H; Soka D; Mmbando B; Msaki E; Kolder I; Thein SL; Menzel S; Cox SE; Makani J; Barrett JC
    PLoS One; 2014; 9(11):e111464. PubMed ID: 25372704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective purging of autologous hematopoietic stem cells using anti-B-cell monoclonal antibody-coated high-density microparticles prior to high-dose therapy for patients with non-Hodgkin's lymphoma.
    Webb IJ; Friedberg nW; Gribben JG; Fisher DC; Spitzer T; Neuberg D; Jallow H; Kim H; Houde H; Monroy R; Schmittling R; Freedman AS
    Biol Blood Marrow Transplant; 2002; 8(8):429-34. PubMed ID: 12234168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation.
    LaCasse EC; Bray MR; Patterson B; Lim WM; Perampalam S; Radvanyi LG; Keating A; Stewart AK; Buckstein R; Sandhu JS; Miller N; Banerjee D; Singh D; Belch AR; Pilarski LM; Gariépy J
    Blood; 1999 Oct; 94(8):2901-10. PubMed ID: 10515895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation.
    Sehn LH; Antin JH; Shulman LN; Mauch P; Elias A; Kadin ME; Wheeler C
    Blood; 1998 Jan; 91(2):717-23. PubMed ID: 9427731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host genetic susceptibility to Clostridium difficile infections in patients undergoing autologous stem cell transplantation: a genome-wide association study.
    Apewokin S; Lee JY; Goodwin JA; McKelvey KD; Stephens OW; Zhou D; Coleman EA
    Support Care Cancer; 2018 Sep; 26(9):3127-3134. PubMed ID: 29594489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High-dose chemotherapy with autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in complete response as consolidation therapy, second report].
    Yamane T; Hirose A; Nakajima Y; Nakane T; Koh H; Takeoka Y; Nakamae M; Yamamura R; Nakamae H; Nakao Y; Mugitani A; Yagi T; Teshima H; Hino M
    Gan To Kagaku Ryoho; 2006 Feb; 33(2):193-8. PubMed ID: 16484855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.